Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sagar P. Patel, MD"'
Autor:
Alexander Gitin, BS, Sagar P. Patel, MD, Angela Weatherall, MD, Vladimir Vincek, MD, PhD, Kiran Motaparthi, MD
Publikováno v:
JAAD Case Reports, Vol 29, Iss , Pp 134-138 (2022)
Externí odkaz:
https://doaj.org/article/4b31414c593b4e15a880f72bd35bf3c4
Publikováno v:
JAAD Case Reports, Vol 27, Iss , Pp 29-31 (2022)
Externí odkaz:
https://doaj.org/article/bcefa2c6c4c6435ba92afb638364ce66
Autor:
Mingyao Zhu, PhD, Katja Langen, PhD, Elizabeth M. Nichols, MD, Yuting Lin, PhD, Stella Flampouri, PhD, Karen D. Godette, MD, Sunil W. Dutta, MD, Mark W. McDonald, MD, Sagar A. Patel, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 1, Pp 100825- (2022)
Purpose: Proton beam therapy can significantly reduce cardiopulmonary radiation exposure compared with photon-based techniques in the postmastectomy setting for locally advanced breast cancer. For patients with metallic port tissue expanders, which a
Externí odkaz:
https://doaj.org/article/a6352d3f909c43e0a6da1e895b36484a
Autor:
Jun Zhou, PhD, Xiaofeng Yang, PhD, Chih-Wei Chang, PhD, Sibo Tian, MD, Tonghe Wang, PhD, Liyong Lin, PhD, Yinan Wang, MS, James Robert Janopaul-Naylor, MD, Pretesh Patel, MD, John D. Demoor, MS, Duncan Bohannon, MS, Alex Stanforth, MS, Bree Eaton, MD, Mark W. McDonald, MD, Tian Liu, PhD, Sagar Anil Patel, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 1, Pp 100826- (2022)
Purpose: While intensity modulated proton therapy can deliver simultaneous integrated boost (SIB) to the dominant intraprostatic lesion (DIL) with high precision, it is sensitive to anatomic changes. We investigated the dosimetric effects from these
Externí odkaz:
https://doaj.org/article/60f7b3db7b904d268e72b3eb18e98c91
Autor:
Neal S. McCall, MD, Yuan Liu, PhD, Sagar A. Patel, MD, Bruce Hershatter, MD, Drew Moghanaki, MD, Karen D. Godette, MD, Sheela Hanasoge, MD, PhD, Pretesh Patel, MD, Benjamin W. Fischer-Valuck, MD, Joseph W. Shelton, MD, Ashesh B. Jani, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 6, Pp 100803- (2021)
Purpose: Treatment with long-term androgen deprivation therapy (ADT) and radiation therapy (RT) is the nonsurgical standard-of-care for patients with high- or very high-risk prostate cancer (HR-PC), but the optimal timing between ADT and RT initiatio
Externí odkaz:
https://doaj.org/article/510c544551994ec9be4490c754652515